Dr. Lazar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
17328 Ventura Blvd
Encino, CA 91316Phone+1 818-990-9572
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1980 - 1983
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1976 - 1979
Loyola University Chicago Stritch School of MedicineClass of 1976
Certifications & Licensure
CA State Medical License 1977 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 13 citationsEMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells.Christen Dillard, Meagan Kiyohara, Vei Mah, Sean P. McDermott, Dana Bazzoun
Molecular Cancer Therapeutics. 2020-05-25 - 8 citationsHuman granulocytes lack red cell Kx antigen.Donald R. Branch, Laima Gaidulis, Gary S. Lazar
British Journal of Haematology. 1986-04-01 - A gene-controlling response of bone marrow progenitor cells to granulocyte-macrophage colony stimulating factors.Gary S. Lazar, Diana H. Quon, Aldons J. Lusis
Journal of Cellular Physiology. 1985-08-01
Press Mentions
OncoResponse Adds Anti-EMP2 Antibody to Oncology PipelineNovember 7th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
